about
SOD1 and amyotrophic lateral sclerosis: mutations and oligomerizationAccumulation of rhodopsin in late endosomes triggers photoreceptor cell degenerationGlutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's diseaseApolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseAtaxin-7 associates with microtubules and stabilizes the cytoskeletal network.Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunctionHDAC6 and microtubules are required for autophagic degradation of aggregated huntingtinCDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegenerationHuntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review seriesAutophagy and the ubiquitin-proteasome system: collaborators in neuroprotectionCytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregatesUnscrambling an egg: protein disaggregation by AAA+ proteinsThe extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivoUsing C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseasesSOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesisThe unfolded protein response in neurodegenerative diseases: a neuropathological perspectiveHow structure shapes (dys)function: a perspective to understanding brain region-specific degeneration in prion diseaseTargeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueNeuroinflammation in overnutrition-induced diseasesHDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?A genetic screening strategy identifies novel regulators of the proteostasis networkTafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeCerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?Role of neuroinflammation in neurodegenerative diseases (Review)Proteomics of protein post-translational modifications implicated in neurodegenerationThe Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's DiseaseCell death in the nervous systemTrehalose induced antidepressant-like effects and autophagy enhancement in miceBAG-6 is essential for selective elimination of defective proteasomal substratesMicrotubule-dependent oligomerization of tau. Implications for physiological tau function and tauopathiesMicrosatellite-encoded domain in rodent Sry functions as a genetic capacitor to enable the rapid evolution of biological noveltyInfluence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid PolypeptideRNA Remodeling Activity of DEAD Box Proteins Tuned by Protein Concentration, RNA Length, and ATPElevated gene expression levels distinguish human from non-human primate brainsDifferential effects of glycation on protein aggregation and amyloid formation.Ortho-methylated 3-hydroxypyridines hinder hen egg-white lysozyme fibrillogenesis.Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregationReview of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compoundsIntrinsic fibrillation of fast-acting insulin analogs.
P2860
Q21090100-586A97D7-D71D-40FE-AEF0-62F36659EE27Q21145009-AB77DC5A-0819-4F48-B04F-3EC08A25C2E9Q21261464-A9E746CB-E88F-4172-AC78-BA5A24A75B66Q22248091-A3FBB4A8-4BF4-43DE-B588-1D4E15A5D821Q24297932-154D7798-F98A-4E95-8A3D-799A8C38C8AAQ24298689-173DF9AB-1902-47E8-8935-880215104C61Q24336179-89340323-F2BF-4E39-BFBD-8088277698F5Q24337155-98A8418C-55F8-4410-BA9D-C0BFBF529136Q24337541-C09BB4D6-A0BD-4715-AAD4-F53C3E7E1C0FQ24537164-D6B22834-673A-4EEB-9A2F-29CD6738749FQ24650675-04B62007-7C4D-42CD-A37C-94511ADC37F4Q24657543-AE1069F5-19B2-4298-A662-BF3A57BB88E5Q24791943-D137A27B-C20A-4F70-B838-6B9ECB95D111Q26751400-6993E76A-AF25-4D96-B56A-2F7981BFD69BQ26776093-D55FECFC-794E-4D87-ADFD-87DB250D3B72Q26785352-467052E0-5D89-4122-B52C-A166BCE5A00AQ26799511-E243DDC5-D07D-4C4C-BD2C-F494C5F6F5BCQ26825281-12E8FEC7-BB26-44C5-9DE5-280B8C608E0EQ26852041-5A2A3963-78D2-4630-94B1-625634345041Q27013624-ACF18A5E-0672-4E8C-AB8C-56AA58986D64Q27015801-5EF20806-74B4-4AB4-9690-34455ACB92A6Q27335238-AA74E880-4F14-4A4E-82EB-B58B13FCAF86Q27679360-73F895E8-1246-4BC3-A37F-C906F1C20FF8Q27693854-5E7A14B6-8018-41CD-AAF7-933371C36237Q28080292-F8F8405E-1150-49F1-AA17-5BF87FA38E93Q28088631-D7A28B71-4C3B-4C48-9A30-592EA55CB55DQ28254943-196539BA-4DFC-4CEA-813C-E66C203862F0Q28269343-C921F761-2FE2-44F8-8791-E74B4E664A6EQ28290140-2D2B9F18-5260-49C5-A399-BC461D24B607Q28505838-91D49545-7D4A-4BEE-A069-B31C2DA5F4B5Q28576082-F4388696-BE92-45CD-B0F4-E4C5434BF538Q28681825-C65571D6-40FD-4CAE-B656-6662B94DC661Q28818425-31BF4A86-4584-4817-9237-4F5092553CC5Q28910444-79B3EA94-4BE6-43BB-8864-E8DE41B16506Q29618585-FFFDC0EC-5503-4685-9EBD-4DB9DEE93BA2Q30374807-45B2E507-1486-4434-9A1C-29CA6286702DQ30376637-F4C44E1B-73E7-48B6-93E8-69968A389076Q30377831-27D29FDE-25C0-450C-BC9C-472478D2C97DQ30408018-0BC41CB4-74AB-4797-BED9-72D775C54A4DQ30416114-4B376BC6-7499-4D47-9D0E-72529086398B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Toxic proteins in neurodegenerative disease.
@ast
Toxic proteins in neurodegenerative disease.
@en
Toxic proteins in neurodegenerative disease.
@nl
type
label
Toxic proteins in neurodegenerative disease.
@ast
Toxic proteins in neurodegenerative disease.
@en
Toxic proteins in neurodegenerative disease.
@nl
prefLabel
Toxic proteins in neurodegenerative disease.
@ast
Toxic proteins in neurodegenerative disease.
@en
Toxic proteins in neurodegenerative disease.
@nl
P356
P1433
P1476
Toxic proteins in neurodegenerative disease.
@en
P2093
J Paul Taylor
Kenneth H Fischbeck
P304
P356
10.1126/SCIENCE.1067122
P407
P577
2002-06-01T00:00:00Z